MedPath
HSA Approval

NIXODERM OINTMENT

SIN04418P

NIXODERM OINTMENT

NIXODERM OINTMENT

May 3, 1990

SUMMIT COMPANY (SINGAPORE) PRIVATE LIMITED

SUMMIT COMPANY (SINGAPORE) PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSUMMIT COMPANY (SINGAPORE) PRIVATE LIMITED
Licence HolderSUMMIT COMPANY (SINGAPORE) PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

OINTMENT

TOPICAL

Medical Information

D02AF

水杨酸制剂

Manufacturer Information

SUMMIT COMPANY (SINGAPORE) PRIVATE LIMITED

NATURAL WELLNESS INDUSTRIES SDN. BHD.

Active Ingredients

SALICYLIC ACID

2.50% w/w

Salicylic acid

PRECIPITATED SULPHUR

4.60% w/w

precipitated sulphur

BENZOIC ACID

6.00% w/w

Benzoic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.